Treatment of oral myiasis in a patient with implant-supported fixed prosthesis

Abstract

Oral myiasis is a rare parasitic disease that requires immediate treatment once diagnosed. However, no standard treatment protocol can be found in the literature. Through a clinical-surgical report, we present the case of an 82-year-old man with lesions extending through the vestibule and alveolar ridge of the maxilla on both sides, in addition to occupying a large part of the palate, with a considerable number of larvae. The patient was initially treated with a single dose of systemic ivermectin (6 mg orally) and topical application of a tampon soaked in ether. The larvae were then surgically removed and debridement of the wound was performed. A crushed tablet of ivermectin 6 mg was applied topically for 2 days, the remaining larvae were again mechanically removed, and the patient received intravenous antimicrobial therapy. Treatment with systemic and topical ivermectin combined with antibiotic therapy and debridement proved to be effective in treating oral myiasis.

Nasal myiasis caused by Musca domestica in patients with respiratory failure: a case report and literature review

“…The primary approach to managing myiasis involves clearing the larvae. Current treatment options include local anesthetic debridement, endoscopic forceps removal, creating a toxic and anaerobic environment using turpentine solution to kill and clear the y larvae, and saline rinses for clearance (Sangalette et al 2023;Sayeed et al 2019). Additionally, appropriate anti-infective therapy should be administered based on the patient's clinical condition.…”